Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome-based dual-modality nanoparticle

FY 2019-20

Summary
Over 28 000 Canadians are diagnosed with lung cancer each year. Improved imaging and screening have increased the number of patients diagnosed with early stage disease, allowing treatment with surgery. However, key treatment decisions (e.g. providing chemotherapy after surgery, deciding the extent of surgery) are based on whether cancer has spread to nearby lymph nodes. Detecting the earliest evidence of cancer spread to lymph nodes remains a challenge in surgical patients. Clinical trials have shown that up to 20% of these patients may have lymph node disease that is missed by standard diagnostic approaches. We will evaluate a new 'dual-mode' dye that can be seen by both CT (a 3D X-ray image) and fluorescence camera. Once injected near a tumour, the dye drains to nearby lymph nodes. The first nodes to 'light up' are the first nodes cancer could spread to, making them key nodes to test for evidence of cancer spread. We will compare this new 'dual-mode' dye with current 'single-mode' dyes that can only be seen by CT or fluorescence camera. Our goal is to see if our new dye is more accurate and easier to use. The lymph node dyes will be studied in preclinical models. First, we will define dye performance with CT scan and fluorescence camera separately. Second, we will look at how injection technique can affect dye performance. Finally, we will compare the 'single-mode' and 'dual-mode' dyes using a combined CT-fluorescence technique in lung tumour models that spread to nearby lymph nodes. This model mirrors what we see in human patients. If we are successful, we will create a powerful new tool for finding key lymph nodes during lung cancer surgery. Information from these nodes would enable doctors and patients to make more informed, personalized treatment discussions with the goal of improving outcomes and quality of life. Given some similarities between cancers, success with lung cancer would suggest our new dye could be useful for other cancer surgery as well.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
417021
Name
Gregor Alexander T
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Enhancing sentinel lymph node mapping in lung cancer surgery using a novel liposome-based dual-modality nanoparticle
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Animal Models; Ct Lymphography; Liposome; Lung Cancer; Lymph Node Staging; Minimally Invasive Surgery; Nanoparticle; Near-Infrared; Sentinel Lymph Node
Abstract
Over 28 000 Canadians are diagnosed with lung cancer each year. Improved imaging and screening have increased the number of patients diagnosed with early stage disease, allowing treatment with surgery. However, key treatment decisions (e.g. providing chemotherapy after surgery, deciding the extent of surgery) are based on whether cancer has spread to nearby lymph nodes. Detecting the earliest evidence of cancer spread to lymph nodes remains a challenge in surgical patients. Clinical trials have shown that up to 20% of these patients may have lymph node disease that is missed by standard diagnostic approaches. We will evaluate a new 'dual-mode' dye that can be seen by both CT (a 3D X-ray image) and fluorescence camera. Once injected near a tumour, the dye drains to nearby lymph nodes. The first nodes to 'light up' are the first nodes cancer could spread to, making them key nodes to test for evidence of cancer spread. We will compare this new 'dual-mode' dye with current 'single-mode' dyes that can only be seen by CT or fluorescence camera. Our goal is to see if our new dye is more accurate and easier to use. The lymph node dyes will be studied in preclinical models. First, we will define dye performance with CT scan and fluorescence camera separately. Second, we will look at how injection technique can affect dye performance. Finally, we will compare the 'single-mode' and 'dual-mode' dyes using a combined CT-fluorescence technique in lung tumour models that spread to nearby lymph nodes. This model mirrors what we see in human patients. If we are successful, we will create a powerful new tool for finding key lymph nodes during lung cancer surgery. Information from these nodes would enable doctors and patients to make more informed, personalized treatment discussions with the goal of improving outcomes and quality of life. Given some similarities between cancers, success with lung cancer would suggest our new dye could be useful for other cancer surgery as well.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gregor, Alexander T
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~